Back to Annual Meeting

Back to Annual Meeting

APHA Scientific Session and Event Listing

Mian B. Hossain, PhD, Biostatistics, School of Public Health and Policy, 343 Jenkins Hall, 1700 E. Cold Spring Lane, Baltimore, MD 21251, Rena Boss-Victoria, DrPH, APN, MSN, RN-, Director/Lecturer: Center for HIV Prevention, Evaluation, Policy & Research, Morgan State University, 343 Jenkins Hall, 1700 E. Cold Spring Lane, Baltimore, MD 21251, and LaKaisha T. Yarber, MS, CHES, School of Public Health and Policy, Morgan State University, 343 Jenkins Hall, 1700 E. Cold Spring Lane, Baltimore, MD 21251, 443-885-4132, LakaishaTYarber@yahoo.com.

Although we are entering the third decade of the HIV pandemic, there is yet no cure or vaccine. Our principal means for deterring the further spread of HIV remain behavioral risk prevention interventions. However, National Institute of Allergy and Infectious Disease (NIAID) are working on the discovery and development of a preventive HIV vaccine. The purpose of this research is to examine the relationship between the perceived trust and willingness to participate in HIV/AIDS vaccine trial among African American college students. The data for this study come from two HBCUs, from a convenient sample of about 1000 students. The data were collected using self-administered questionnaire during 2002 and 2003. Factor scores of trust are generated using factor analysis from several indicators of trust. In addition to univariate and bivariate analysis, multiple logistic regression models are used for examining the relationship between trust and willingness to participate in vaccine trials. The trust appears to be an important factor for determining participation in vaccine trials. Results show that a little more than 60% of the study participants expressed their trust to physicians and other personnel. About 50% of the study participants expressed that they would participate in vaccine trial if they were asked. However, most (90%) of the study participants mentioned that permanent injury and death are the two major concerns that they have related to participation in the vaccine trial. Results show that higher the trust score higher is the odds of willingness to participate in the vaccine trial.

Learning Objectives: At the conclusion of the session, the participants in this session will be able to

• Understand the barriers for willingness to participate in HIV/AIDS vaccine trial.
• Understand the reasons for lack of trust in vaccine trial among African American college students
• Understand the relationship between the trust and the willingness to participate in HIV/AIDS vaccine trials.

Keywords: African American, HIV/AIDS

Presenting author's disclosure statement:

Not Answered